نتائج البحث - Duda, Gabriel

  • يعرض 1 - 2 نتائج من 2
تنقيح النتائج
  1. 1
    CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS

    CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS حسب Reardon, David, Molinaro, Annette, Peters, Katherine, Clarke, Jennifer, Jordan, Justin, de Groot, John, Nghiemphu, Phioanh, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Smith, Timothy, Cote, David, Severgnini, Mariano, Yearley, Jennifer, Zhao, Qing, Blumenschein, Wendy, Duda, Gabriel, Muzikansky, Alona, Jain, Rakesh, Wen, Patrick, Nayak, Lakshmi

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

    NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA حسب Nayak, Lakshmi, Molinaro, Annette, Peters, Katherine, Clarke, Jennifer, Jordan, Justin, de Groot, John, Nghiemphu, Phioanh, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Gaffey, Sarah, Smith, Timothy, Cote, David, Severgnini, Mariano, Yearley, Jennifer, Zhao, Qing, Blumenschein, Wendy, Duda, Gabriel, Muzikansky, Alona, Jain, Rakesh, Wen, Patrick, Reardon, David

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: